On Friday, Ark Invest led by Cathie Wood trimmed several technology holdings across its ARKK and ARKW funds, including Palantir (PLTR), Shopify (SHOP), Alphabet (GOOG) and Cloudflare (NET). ARKW also sold shares of Circle (CRCL), Roblox (RBLX), CrowdStrike (CRWD) and other names. In contrast, the ARKG fund bought biotechnology companies including Pacific Biosciences (PACB), Scribe Therapeutics (SCTX) and Freenome (FRNM), buying 169,498 FRNM shares and 68,266 PACB shares. PACB was also added to ARKK. ARKG closed up nearly 1% in the regular session and rose nearly 0.2% after hours, while retail sentiment on Stocktwits was neutral.
Summary written by Upside AI from the original article. Read the source for full details.
Read the original on Yahoo Finance ↗
Keywords
Cathie WoodETFinvestment truststech stocksbiotechnology
Open a keyword to see other news on the same topic.
Related tickers and likely impact
GOOGL
▼ Likely negativeAlphabet Inc. (Class A)
Relevance: low
| Market | US stocks |
|---|---|
| Sector | Communication Services |
| Industry | Interactive Media & Services |
| Market cap | $4.3T |
| Close on 10/23/2026 | 320.25 |
| Change that session | -1.22% |
Impact is scored by AI from the headline and may be wrong. It is not investment advice.
Related news
- Cathie Wood Bought More CRISPR Therapeutics Stock 2 Days in a Row. Here's What She Sees in the Biotech Stock.
Ark Invest founder Cathie Wood holds $379.1 million of CRISPR Therapeutics shares and bought $1.1 million on Oct. 9 and $2.3 million on Oct. 12 through the ARK Genomic Revolution ETF, even though the stock is down more than 25% over the past year. CRISPR's only approved therapy, Casgevy, posted $76 million in Q2 revenue, up 151% year over year, but its $2.2 million list price and the 60% revenue share going to Vertex limit its economics. The company's net loss narrowed to $91.2 million from $208.5 million, and it holds $2.36 billion in cash. The article also points to CTX-310, which cut LDL cholesterol by 53% and triglycerides by 48% after 12 months in a phase 1a trial, and to a phase 2 readout for blood thinner CTX611 expected later this year.
- Cathie Wood Keeps Buying Beam Therapeutics on the Dip. Should You Follow Her Lead?
Ark Investment Management, led by Cathie Wood, holds $220.4 million in Beam Therapeutics (BEAM) shares through its Ark ETFs, and recently bought another $2.8 million worth on Oct. 12 and 13 for the Ark Genomic Revolution (ARKG) fund. Beam develops gene-editing therapies using base editing, which changes single nucleotides without cutting both DNA strands, and its lead candidate, risto-cel, is in early trials for severe sickle cell disease. The company is far from profitable: first-half revenue was $32.2 million, up 50.5%, and loss per share was $2.09 versus $2.12 a year earlier, while $1.15 billion in cash is expected to fund operations through mid-2029. The stock is down more than 14% this year, and the article notes that the next 12 to 18 months will bring dense data readouts that could significantly lift the shares if positive.
- Invesco Pharmaceuticals ETF vs. iShares Biotechnology ETF: Which Is the Better Buy?
The article compares two healthcare ETFs: PJP, which focuses on pharmaceutical companies, and IBB, which spans 243 biotechnology stocks. IBB has the lower expense ratio at 0.44% versus 0.58% for PJP, while PJP pays higher dividends, $1.13 per share over the trailing 12 months compared with $0.34 for IBB. IBB had a max drawdown of nearly 40% during the 2022 bear market and has a higher beta, indicating more volatility, though it has outperformed PJP over the past year as biotech stocks surged in 2026. PJP has been more stable and has outperformed IBB over five years, with a smaller max drawdown and lower beta. The article concludes that the right choice depends on each investor's goals and risk tolerance.
- VGT Returned 799.70% and VOO Returned 324.46% Over a Decade. Adding VUG Does Not Make It Diversified
The article argues that Vanguard's VOO, VUG and VGT overlap heavily because the same mega-cap tech companies sit near the top of each. Over ten years VGT returned 799.70%, VUG 429% and VOO 324.46%, but the gap reflects one factor, mega-cap tech, held at different concentration levels. VOO has 38.0% of net assets in information technology and VUG 65.9% in technology, while VGT tracks a technology-only index. In the past week VOO fell 1.4%, VUG 3% and VGT 5%, showing that the most concentrated fund dropped the most. The author advises checking each fund's top ten holdings and converting fund weights into portfolio weights to measure real exposure.
- Cathie Wood Trimmed Ark's Alphabet Stake Even as Google Search Revenue Grew, While Ark Piled Into Rocket Lab Even After Its Neutron Launch Delay. Is Ark Betting Against the Wrong AI Winner?
On Sept. 22, Ark Invest bought about $25.1 million of Rocket Lab and sold $5.8 million of Alphabet; after Rocket Lab delayed Neutron's first launch to 2027, Ark bought another $9.3 million on Oct. 15. Alphabet's paid clicks rose 13%, and Google Cloud revenue jumped 82% to $24.8 billion in the second quarter. Ark expects a possible U.S. launch-capacity shortage as SpaceX could retire Falcon 9 by end-2030, while Rocket Lab has a multiyear Synspective deal and a $2.36 billion backlog. However, Rocket Lab trades at over 39 times trailing-12-month sales versus about 9.3 times for Alphabet, and the article argues Alphabet appears to offer the stronger risk-adjusted AI opportunity.
- Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Cathie Wood added to her stakes in CoreWeave (CRWV), Scribe Therapeutics (SCTX) and Freenome (FRNM) on Monday, with all three trading 28% to 57% below their previous highs. CoreWeave's revenue rose 113% in its latest quarter, but analysts don't expect an adjusted profit until 2028, and rising interest rates weigh on the heavily leveraged company; its stock hit a new 52-week low on Tuesday. Scribe went public at $15 in July and peaked at $39.60 a month later before shedding more than half its value, but says its cash funds operations through the first half of 2029. Freenome rose 7% on Monday but remains down nearly 30% from last month's high, after receiving FDA clearance for a lung cancer screening test. The article describes these as three potentially opportunistic purchases.
Related markets
Latest news
- France Deploys 70,000 Police Amid Fears of Widespread Riots
The French government is deploying about 70,000 police nationwide on Oct. 24, roughly 10,000 more than last weekend, ahead of expected protests in major cities. The force includes elite police, mounted officers, helicopters, drones, armoured vehicles and water cannon trucks. Interior Minister Laurent Nunez warned that some groups are using social media to call for attacks on public buildings. The protests, which began with student demands over learning conditions, drew over 500,000 people on Oct. 17, and about 2,700 people have been arrested since then. Paris extended its night curfew to Oct. 26 and Lyon banned gatherings in central areas, but UNEF and the Yellow Vest movement still call for marches.
- Us Consumer Sentiment : From fuel price hikes to cost - of - living concerns , US consumer sentiment nears record low
US consumer sentiment edged down to 48.0 in October, near a record low, as price increases linked to the Middle East conflict weighed on households, according to a University of Michigan survey. Sentiment among independents fell sharply to 42.4 from 47.7 in September, just above May's record low of 40.6, while scores among Democrats and Republicans improved. Expectations for inflation over the next 12 months rose to 4.7%, and expectations for the next five years increased to 3.5%. Survey director Joanne Hsu warned that persistently elevated inflation expectations could complicate the Federal Reserve's efforts to bring inflation to its 2% target, and the Fed is due to meet next week with the policy rate widely expected to stay at 3.75%-4.00%.
- Something in Tehran Resembles What Once Unfolded in Moscow
The author compares the Soviet Union with Iran after reading On the Edge of Empire: From Brezhnev to Putin by journalist Salam Musafir. He argues the two authoritarian systems, one secular and one religious, share weaknesses: a gap between official rhetoric and everyday life, economic stagnation, and costs from foreign ambitions. He says Iranians, especially younger generations, are demanding fair incomes, jobs and personal freedoms, and that grievances such as those illustrated by the 2022 case of Mahsa Amini cannot all be dismissed as the work of foreign agents. While he does not treat every opposition claim as unquestionable, he says their recurring economic complaints deserve examination. He notes that history does not simply repeat itself, but political systems can differ in ideology while sharing the same sources of weakness.
- CBN okay JPMorgan to establish merchant bank in Nigeria
The Central Bank of Nigeria (CBN) has granted Approval-in-Principle to JPMorgan to establish JPMorgan Merchant Bank Nigeria Limited, but the bank must meet further requirements and obtain a final operating licence before it can begin business. Michael Akuka, Director of Corporate Communications and Investor Relations at the CBN, said this is only the first stage, with registration with the Corporate Affairs Commission and other operational arrangements still required. The CBN also approved Adedapo Adedayo Olagunju as managing director, along with several non-executive and independent non-executive directors. Governor Olayemi Cardoso said the goal is a stable, competitive and internationally connected financial system, following the completion of the banking sector recapitalisation exercise.
- Mexican Peso Gains 0 . 3 % on Friday but Ends Week 0 . 8 % Lower
The Mexican peso rebounded against the U.S. dollar on Friday but still finished the week weaker. Banco de México's benchmark was 18.6601 pesos per dollar on Oct. 23, up from 18.5045 on Oct. 16, a 0.84% rise in the peso-per-dollar quote that equals a 0.83% drop in the peso's dollar value. The rate fell from 18.7134 on Oct. 22 to Oct. 23, implying a roughly 0.3% daily gain for the peso. INEGI said its Global Economic Activity Indicator rose 0.6% from July and 3.5% year on year in August, using seasonally adjusted figures. The University of Michigan put its final October Consumer Sentiment Index at 48.0, compared with 48.1 in September.
- Bank of Italy Scotti Urges Staged Investment in Digital Finance
Bank of Italy Deputy Governor Chiara Scotti urged lenders to build adaptable digital-finance systems and test them in limited stages, since demand and the market's eventual design remain uncertain. She warned that customers may reach financial services through interfaces controlled by platforms, which could make banks less visible. A Boston Consulting Group model estimated that a regional bank pairing digital-asset custody with other services could add $80 million to $100 million in profit, though this was modelled rather than reported earnings. ECB data put tokenized assets on public blockchains at €38 billion in February 2026, up from €7.4 billion in early 2024. The Eurosystem launched Pontes on Sept. 21 to settle wholesale transactions in tokenized assets in central bank money.
Get the briefing on Telegram or Zalo
Join the Upside Telegram channel or Zalo group for the Vietnam stocks and gold briefing at 8:00 and 19:00 (Vietnam time) on trading days, plus a weekly wrap on Saturday morning.